The FDA is reviewing Pfizer's vaccine that protects infants against RSV and could make a decision to clear the shot as soon as August. The single-dose vaccine is given to pregnant women late in pregnancy to trigger antibodies that are passed to the fetus. This comes after cases of RSV rose drastically last fall after mask wearing and social distancing dropped off